Program Medium
Internet-based program
Method of Physician Participation Utilized in Learning Process
There are no fees for participating and receiving CME credit for this activity. During the period September 22, 2017 through September 22, 2019, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity, and are expected to view all 96 segments, totaling 4.5 hours, to successfully complete the activity and earn CME credit; 3) register and complete the evaluation form and post-test; 4) score 100% on the post-test; and 5) print out CME certificate.
Estimated Time to Complete Educational Activity
4.5 hours. Physicians must study the enduring activity, and are expected to view every segment to successfully complete the activity and earn CME credit.
Course Overview
In this web-based program, physicians will learn how recent advances in basic and clinical research have helped to improve the understanding the use of genomics in cancer treatment.
Release Date
September 22, 2017
Expiration Date
September 22, 2019
Intended Audience
This complimentary CME educational activity is designed for all healthcare providers (HCPs) involved in developing, delivering, consulting, and monitoring care for patients with or at risk for cancer.
This constituency of HCPs shall include the following audience:
Registration
Participation in this iQ&A interactive Medical Intelligence Zone is complimentary, and clinicians are invited to view this CME-certified program and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.
Grantor Support
This activity is supported by an independent medical education grant from Roche Singapore Pte Ltd.
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Massachusetts Medical School Office of Continuing Medical Education (UMMS-OCME) and CMEducation Resources, LLC. The UMMS-OCME is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Massachusetts Medical School designates this enduring material for a maximum of 4.5 AMA PRA Category 1 Credits(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Policy on Faculty & Provider Disclosure
It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.
Program Faculty and Disclosure
Prof. Jean-Yves Blay, MD, PhD
Professor of Medicine
Université Claude Bernard
Lyon, France
Scientific Director, Canceropole
Research Support and Honoraria: Novartis, Roche, GSK BMS, MSD, Pharmamar
Professor Hyun Cheol Chung, MD
Professor of Medical Oncology
Yonsei Cancer Center Director
Yonsei Song-Dang Institute for Cancer Research
Yonsei University College of Medicine
Seoul, Korea
Nothing to disclose
Professor Byoung Chul Cho, MD, PhD
Yonsei Cancer Center
Yonsei University College of Medicine
JE-UK Laboratory of Molecular Cancer Therapeutics
Seoul, Korea
Nothing to disclose
Prof. Johann De Bono, MD, PhD
Professor of Experimental Cancer Medicine
Honorary Consultant Medical Oncologist
Royal Marsden Hospital
Head of the Division of Clinical Studies
Institute of Cancer Research
London, UK
Nothing to disclose
Rodrigo Dienstmann, MD
Principal Investigator
Oncology Data Science (ODysSey) Group
Vall d'Hebron Institute of Oncology
Barcelona, Spain
Computational Oncology Group
Sage Bionetworks
Seattle, Washington, USA
Nothing to disclose
Seung Tae Kim, MD
Division of Hematology Oncology
Department of Medicine
Samsung Medical Center
Sungkyunkwan University School of Medicine
Seoul, Korea
Nothing to disclose
Samuel Klempner, MD
Director of Precision Medicine
The Angeles Clinic and Research Institute
Cedars-Sinai Medical Center
Los Angeles, California, USA
Speaker’s Bureau: FoundationOne
Advisory Board: Lilly Oncology
Prof. Matthew Krebs, MD, PhD
Clinical Senior Lecturer
Experimental Cancer Medicine
Honorary Consultant
Medical Oncology
The University of Manchester
Greater Manchester, UK
Nothing to disclose
Razelle Kurzrock, MD
Chief, Division of Hematology and Oncology
UCSD School of Medicine
Senior Deputy Director, Clinical Science
Director, Center for Personalized Cancer Therapy
Director, Clinical Trials Office
UCSD Moores Cancer Center
San Diego, California
Nothing to disclose
Prof Frédérique Penault-Llorca, MD
Chief Executive Officer
Jean Perrin Comprehensive Cancer Center
Professor of Pathology
Head of the Department of Pathology and Tumor Biology
Clermont-Ferrand, France
Nothing to disclose
Jean-Charles Soria, MD
Professor of Medicine and Medical Oncology
South-Paris University
Cancer Specialist
Institut Gustave Roussy (IGR)
Paris, France
Advisor or Consultant: Roche, AstraZeneca, and MSD.
Dr. Daniel SW Tan
Medical Oncology
Senior Consultant
National Cancer Centre Singapore
Clinician-Scientist Fellow, The Genome Institute
Singapore
Nothing to disclose
Janice Tsang, MBBS, MRCP (UK), FRCP (Lond.)
Specialist in Medical Oncology
Hon. Clinical Assistant Professor
Li Ka Sing Faculty of Medicine
The University of Hong Kong
Hong Kong, China
Nothing to disclose
Lia Tsimberidou, MD, PhD
Tenured Associate Professor
Department of Investigational Cancer Therapeutics
Division of Cancer Medicine
The University of Texas
MD Anderson Cancer Center
Houston, TX
Research Funding: Foundation Medicine
Professor Lynn Wang, MD, PhD, FCAP
Professor, Division of Genomic and Molecular Pathology
Founding Medical Director
Genomic and Molecular Pathology
University of Chicago Medical Center
Chicago, Illinois USA
Nothing to disclose
Dr. Wong Seng Weng, MBBS, MRCP(UK), FAMS (Medical Oncology)
Medical Director & Consultant Medical Oncologist
The Cancer Centre (Singapore Medical Group)
Paragon Medical & Mt Elizabeth Novena
Specialist Centre Visiting Consultant
Mt Elizabeth Hospital & Mt Elizabeth Novena Hospital
Adjunct Clinician Scientist
Institute of Bioengineering & Nanotechnology (IBN)
Agency for Science, Technology & Research (A*STAR)
Singapore
Honoraria: Astra Zeneca, Bayer Schering Pharma, Bristol-Myers Squibb, Eisai, Eli Lilly, Hospira, Merck Serono, Merck Sharp & Dohme (MSD), Mundipharma, Novartis, Orient Europharma, Pfizer, Roche
Advisory Boards: Astra Zeneca, Bayer, Schering Pharma, Bristol-Myers Squibb, Eli Lilly, Hospira, Merck Serono, Merck Sharp & Dohme (MSD), Novartis, Orient Europharma, Pfizer, Roche
Professor James CH Yang, MD, PhD
Professor, Graduate Institute of Oncology
National Taiwan University
Director, Department of Oncology
National Taiwan University Hospital
Taipei, Taiwan
Honoraria for speaking or advisory board: Boehringer Ingelheim, Eli Lilly, Bayer, Roche/Genentech/Chugai, Astellas, MSD, Merck Serono, Pfizer, Novartis, Clovis Oncology, Celgene, Merrimack, Yuhan Pharmaceuticals, BMS, Ono Pharmaceutical, Daiichi Sankyo and AstraZeneca
Program Managers and Web Editor Disclosure
Program Manager Gideon Bosker, MD has nothing to disclose.
Program Reviewer Denise Leary has nothing to disclose.
Educational Objectives
Upon completion of this activity, participants will be able to:
Hardware and Software Requirements:
To participate in this program, viewers must have a PC or Macintosh computer that has active, ongoing internet access for the duration of the program, as well as a compatible Flash-viewer. An email address is required for registration, and a printer is required to print out the CME certificate.
Privacy Policy
When you participate in a CME activity offered by CMEducation Resources, we ask you for your name, degree, affiliation, street address, telephone number, fax number, and/or e-mail address (the "Information"). We use that Information in the following ways:
Disclaimer
Copyright © 2017 by CMEducation Resources, LLC All rights reserved.
Reproduction, distribution, or translation without express written permission is strictly prohibited.
Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.
Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.
Opinions expressed herein are not necessarily those of Pharmatecture, LLC, CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.